SequenceBase, a Edison, New Jersey-based provider of patent sequence information and search technology to the biotech, pharmaceutical and chemical industries is being acquired by Clarivate Analytics plc, a provider of insights and analytics. The acquisition is expected to deliver an expanded solution to the fast-growing biologics market.

"The acquisition confirms our commitment to the IP life science community and will allow us to better serve our customers' growing needs for high quality, intuitive solutions for sequence-oriented patent research," said Dan Videtto, President, Derwent, Clarivate Analytics. "Through the combination of the SequenceBase platform with proprietary USGENE and WOGENE databases and GENESEQ content, customers can now better understand the sequence landscape, enabling them to quickly assess patentability, identify potential infringing patents and track competitor activities."